| Literature DB >> 33854674 |
Salma Charfeddine1, Leila Abid1, Rania Hammami1, Amine Bahloul1, Faten Triki1, Samir Kammoun1.
Abstract
INTRODUCTION: our aim was to investigate the value of conventional echocardiography, pulsed Doppler and speckle tracking imaging (STI) analysis in the assessment of the left ventricular (LV) myocardial function in hemodialysis (HD) patients with preserved LV ejection fraction and to evaluate the effect of a single HD session on the LV systolic and diastolic functions.Entities:
Keywords: Hemodialysis; echocardiography; left ventricular function; speckle tracking imaging; strain
Mesh:
Year: 2021 PMID: 33854674 PMCID: PMC8017366 DOI: 10.11604/pamj.2021.38.45.9407
Source DB: PubMed Journal: Pan Afr Med J
Figure 1demonstration of two-dimensional speckle tracking imaging (2D-STI) analysis; after the reference points are set, the software shows the endocardial border tracking in different views; a) the apical 4-chamber view (the endocardial tracking is performed automatically through the entire cardiac cycle by 2D-STI); b) the LV longitudinal time velocity curves obtained from the apical 4- 3- and 2- chamber views in hemodialysis patients
Figure 2demonstration of three-dimensional speckle tracking imaging (3D-STI) analysis; after the reference points are set, the software shows the endocardial border tracking in different views; apical 4-chamber view, apical 2-chamber view, apical left ventricular longitudinal view; and three short-axis views from apex to base; the endocardial tracking is performed automatically through the entire cardiac cycle by 3D-STI
baseline characteristics of the study population (30 patients)
| Variable | Number, % |
|---|---|
| Age (years (SD)) | 44.93 (13.4) |
| Male | 19 (63.3%) |
| Systemic hypertension | 13 (43.3%) |
| Diabetes | 4 (13.3%) |
| Dyslipidaemia | 10 (33.3%) |
| Average duration of chronic HD (years (SD)) | 7.14 (5.9) |
| Fluid removal (L (SD)) | 2.26 (0.5) |
| Cause of end-stage renal disease | |
| Interstitial nephritis | 6 (20%) |
| Glomerulonephritis | 4 (13.3%) |
| Vascular nephritis | 3 (10%) |
| Diabetic nephritis | 2 (6.7%) |
| Hereditary | 2 (6.7%) |
| Unknown | 13 (43.3%) |
| HD: hemodialysis | |
variables before and after hemodialysis in the study population
| Variable | Pre-HD | Post-HD | p-value |
|---|---|---|---|
| Clinical variables | |||
| Systolic BP (mmHg) | 126.97 (16.09) | 116.93 (15.10) | |
| Diastolic BP (mmHg) | 80.23 (8.15) | 73.27 (8.02) | |
| Heart rate (bpm) | 78.46 (13.68) | 75.36 (10.98) | 0.247 |
| Body weight (kg) | 62.31 (9.56) | 60.55 (9.61) | |
| BSA (m2) | 1.68 (0.15) | 1.65 (0.15) | |
| Laboratory tests | |||
| BNP (pg/mL) | 253.33 (222.90) | 221.56 (197.79) | |
| Urea (mmol/L) | 22.53 (5.07) | 5.27 (2.99) | |
| Creatinine (µmol/L) | 849.43 (147.90) | 246.17 (103.87) | |
| Calcemia (mmol/L) | 2.23 (0.20) | 2.55 (0.20) | |
| Phosphoremia(mmol/L) | 1.67 (0.50) | 0.66 (0.30) | |
Data are presented as mean (SD) BP: blood pressure, BSA: body surface area, BNP: brain natriuretic peptide
comparison of MM and 2D-echocardiographic parameters before and after hemodialysis in the study population
| Parameter | Pre-HD | Post-HD | p-value |
|---|---|---|---|
| LA diameter (mm) | 38.93 (5.28) | 36.30 (4.19) | |
| LA area (cm2) | 19.27 (3.29) | 17.00 (3.45) | |
| LA volume (ml/m2) | 38.90 (14.52) | 36.74 (12.70) | |
| LVEDd (mm) | 53.20 (6.44) | 48.60 (4.47) | |
| LVESd (mm) | 31.20 (4.44) | 28.76 (4.38) | |
| IVST (mm) | 11.03 (2.02) | 10.86 (2.06) | 0.67 |
| LVPWT (mm) | 12.73 (2.34) | 12.40 (2.22) | 0.36 |
| LVMi (g/m2) | 134.37 (49.10) | 111.56 (34.83) | |
| 2D-LVEDVi (mL/m2) | 60.04 (12.89) | 56.38 (11.99) | |
| 2D-LVESVi (mL/m2) | 23.53 (6.71) | 20.52 (4.70) | |
| LVFS (%) | 41.06 (4.83) | 40.13 (6.67) | 0.49 |
| LVEFs (%) | 61.36 (7.87) | 62.36 (8.51) | 0.53 |
| Inferior vena cava diameter (mm) | 13.16 (3.38) | 10.23 (3.49) |
Data are presented as mean (SD) LA: left atrial, IVST: interventricular septal thickness, LVPWT: left ventricular posterior wall thickness, LVEDd: left ventricular end-diastolic dimension, LVESd: left ventricular end-systolic dimension, LVMi: left ventricular mass index, 2D-LVEDVi: two-dimensional left ventricular end diastolic volume index, 2D-LVESVi: two-dimensional left ventricular end systolic volume index, LVFS: left ventricular fractional shortening, LVEFs: left ventricular ejection fraction calculated by biplane Simpson method.
comparison of Doppler indices before and after hemodialysis in the study population
| Parameter | Pre-HD | Post-HD | p-value |
|---|---|---|---|
| Peak E (cm/sec) | 96.06 (21.86) | 80.00 (21.32) | |
| Peak A (cm/sec) | 84.16 (19.87) | 80.00 (20.32) | 0.07 |
| E/A ratio | 1.20 (0.35) | 1.04 (0.32) | |
| DT (msec) | 174.96 (41.76) | 189.00 (46.85) | 0.08 |
| IVRT (msec) | 89.20 (17.87) | 88.13 (18.51) | 0.75 |
| Systolic wave (cm/sec) | 10.60 (3.53) | 11.43 (3.42) | 0.15 |
| E’ peak velocity (cm/sec) | 12.70 (3.98) | 12.00 (3.59) | 0.16 |
| A’ peak velocity (cm/sec) | 11.43 (3.61) | 10.66 (3.51) | 0.10 |
| E’/A’ ratio | 1.23 (0.62) | 1.26 (0.70) | 0.63 |
| Peak S (cm/sec) | 68.20 (13.64) | 61.90 (15.10) | |
| Peak D (cm/sec) | 57.20 (10.04) | 50.50 (12.40) | |
| S/D ratio | 1.21 (0.29) | 1.26 (0.33) | 0.51 |
| E/E’ (lateral) | 8.18 (2.84) | 7.12 (2.46) | |
| Vp (cm/sec) | 78.50 (24.76) | 68.56 (23.70) | 0.14 |
| E/Vp | 1.31 (0.44) | 1.24 (0.44) | 0.41 |
| dAp-Am (msec) | -43.53 (35.00) | -37.30 (26.01) | 0.26 |
| PAPS (mmHg) | 34.63 (8.67) | 27.40 (6.74) | |
| Elevated LV filling pressure | 10 (33.3%) | 1 (3.33%) | |
Data are presented as mean (SD)
comparison of the three-dimensional volumetric findings and the 2D and 3D- strain parameters before and after hemodialysis in the study population
| Parameter | Pre-HD | Post-HD | p-value |
|---|---|---|---|
| 3D-LVEDVi (mL/m2) | 59.67 (19.53) | 54.49 (15.09) | |
| 3D-LVESVi (mL/m2) | 24.57 (9.48) | 21.93 (5.74) | |
| 3D-LAESVi (mL/m2) | 35.60 (12.25) | 31.23 (10.12) | |
| 3D-LAEDVi (mL/m2) | 22.53 (11.82) | 19.06 (7.96) | |
| 3D-LVEF (%) | 58.46 (7.14) | 58.90 (7.03) | 0.74 |
| 3D-LAEF (%) | 37.66 (17.65) | 39.65 (13.32) | 0.53 |
| LVMi (g/m2) | 99.13 (18.06) | 80.82 (18.27) | |
| 2D-GLS (%) | -16.43 (1.73) | -18.49 (1.92) | |
| 2D-GRS (%) | 23.94 (9.25) | 30.41 (14.10) | |
| 2D-GCS (%) | -20.23 (3.42) | -21.46 (4.92) | 0.11 |
| LAS (%) | 31.55 (9.53) | 34.77 (10.88) | |
| 3D-GLS (%) | -15.30 (3.23) | -17.16 (2.75) | |
| 3D-GRS (%) | 22.46 (6.27) | 27.15 (9.10) | |
| 3D-GCS (%) | -19.43 (4.52) | -21.26 (3.72) | |
Data are presented as mean (SD) 3D-LVEDVi: three-dimensional left ventricular end diastolic volume index, 3D-LVESVi: three-dimensional left ventricular end systolic volume index, 3D-LAEDVi: three-dimensional left atrial end diastolic volume index, 3D-LAESVi: three-dimensional left atrial end systolic volume index, 3D-LVEF: three-dimensional left ventricular ejection fraction, 3D-LAEF: three-dimensional left atrial ejection fraction, LVMi: left ventricular mass index, 2D-GLS: two-dimensional global longitudinal strain, 2D-GRS: two-dimensional global radial strain, 2D-GCS: two-dimensional global circumferential strain, LAS: left atrial strain, 3D-GLS: three-dimensional global longitudinal strain, 3D-GRS: three-dimensional global radial strain, 3D-GCS: three-dimensional global circumferential strain.
correlations between strain values, LVEF, BNP and LVMi before and after hemodialysis
| GLS | GRS | GCS | 3D-GLS | |||||
|---|---|---|---|---|---|---|---|---|
| Pre-HD | Post-HD | Pre-HD | Post-HD | Pre-HD | Post-HD | Pre-HD | Post-HD | |
| -0.421* | -0.537** | -0.410* | -0.580** | -0.261 | -0.278 | -0.433* | -0.619** | |
| -0.418* | -0.406* | -0.372 | -0.366 | -0.176 | -0.216 | -0.777** | -0.685** | |
| -0.433* | -0.456* | -0.275 | -0.331 | -0.216 | -0.318 | -0.673** | -0.713** | |
p < 0.05, **p < 0.01 LVEF: left ventricular ejection fraction, LVMi: left ventricular mass index, BNP: brain natriuretic peptide, GLS: two-dimensional global longitudinal strain, GRS: two-dimensional global regional strain, GCS: two-dimensional global circumferential strain, 3D-GLS: three-dimensional global longitudinal strain.